These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 26749507)
21. Proteomic Analysis of the Human Olfactory Bulb. Dammalli M; Dey G; Madugundu AK; Kumar M; Rodrigues B; Gowda H; Siddaiah BG; Mahadevan A; Shankar SK; Prasad TSK OMICS; 2017 Aug; 21(8):440-453. PubMed ID: 28816642 [TBL] [Abstract][Full Text] [Related]
22. Mitochondrial proteome: toward the detection and profiling of disease associated alterations. Herrmann PC; Herrmann EC Methods Mol Biol; 2012; 823():265-77. PubMed ID: 22081351 [TBL] [Abstract][Full Text] [Related]
23. Unraveling the exercise-related proteome signature in heart. Ferreira R; Moreira-Gonçalves D; Azevedo AL; Duarte JA; Amado F; Vitorino R Basic Res Cardiol; 2015 Jan; 110(1):454. PubMed ID: 25475830 [TBL] [Abstract][Full Text] [Related]
24. Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease. Büeler H Apoptosis; 2010 Nov; 15(11):1336-53. PubMed ID: 20131004 [TBL] [Abstract][Full Text] [Related]
25. Profiling of mitochondrial proteome in wheat roots. Kim DE; Roy SK; Kamal AH; Cho K; Kwon SJ; Cho SW; Park CS; Choi JS; Komatsu S; Lee MS; Woo SH Mol Biol Rep; 2014 Aug; 41(8):5359-66. PubMed ID: 24958017 [TBL] [Abstract][Full Text] [Related]
26. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease. Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676 [TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways. Soreq L; Ben-Shaul Y; Israel Z; Bergman H; Soreq H Neurobiol Dis; 2012 Mar; 45(3):1018-30. PubMed ID: 22198569 [TBL] [Abstract][Full Text] [Related]
28. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein. Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531 [TBL] [Abstract][Full Text] [Related]
29. Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD. Mandel SA; Fishman T; Youdim MB Parkinsonism Relat Disord; 2007; 13 Suppl 3():S242-7. PubMed ID: 18267243 [TBL] [Abstract][Full Text] [Related]
30. Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease. Chou JL; Shenoy DV; Thomas N; Choudhary PK; Laferla FM; Goodman SR; Breen GA J Proteomics; 2011 Apr; 74(4):466-79. PubMed ID: 21237293 [TBL] [Abstract][Full Text] [Related]
31. Differential proteome of the striatum from hemiparkinsonian rats displays vivid structural remodeling processes. Lessner G; Schmitt O; Haas SJ; Mikkat S; Kreutzer M; Wree A; Glocker MO J Proteome Res; 2010 Sep; 9(9):4671-87. PubMed ID: 20666516 [TBL] [Abstract][Full Text] [Related]
32. Molecular insights into Parkinson's disease. Rochet JC; Hay BA; Guo M Prog Mol Biol Transl Sci; 2012; 107():125-88. PubMed ID: 22482450 [TBL] [Abstract][Full Text] [Related]
33. The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease. Esteves AR; Gozes I; Cardoso SM Biochim Biophys Acta; 2014 Jan; 1842(1):7-21. PubMed ID: 24120997 [TBL] [Abstract][Full Text] [Related]
34. Characterization of nonmotor behavioral impairments and their neurochemical mechanisms in the MitoPark mouse model of progressive neurodegeneration in Parkinson's disease. Langley MR; Ghaisas S; Palanisamy BN; Ay M; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG Exp Neurol; 2021 Jul; 341():113716. PubMed ID: 33839143 [TBL] [Abstract][Full Text] [Related]
36. Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells. Jin J; Davis J; Zhu D; Kashima DT; Leroueil M; Pan C; Montine KS; Zhang J BMC Neurosci; 2007 Aug; 8():67. PubMed ID: 17705834 [TBL] [Abstract][Full Text] [Related]
37. Control of mitochondrial integrity in Parkinson's disease. Vives-Bauza C; Tocilescu M; Devries RL; Alessi DM; Jackson-Lewis V; Przedborski S Prog Brain Res; 2010; 183():99-113. PubMed ID: 20696317 [TBL] [Abstract][Full Text] [Related]
38. Parkin maintains mitochondrial levels of the protective Parkinson's disease-related enzyme 17-β hydroxysteroid dehydrogenase type 10. Bertolin G; Jacoupy M; Traver S; Ferrando-Miguel R; Saint Georges T; Grenier K; Ardila-Osorio H; Muriel MP; Takahashi H; Lees AJ; Gautier C; Guedin D; Coge F; Fon EA; Brice A; Corti O Cell Death Differ; 2015 Oct; 22(10):1563-76. PubMed ID: 25591737 [TBL] [Abstract][Full Text] [Related]
39. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease. Zuo L; Motherwell MS Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870 [TBL] [Abstract][Full Text] [Related]
40. Mitophagy and Parkinson's disease: be eaten to stay healthy. de Vries RL; Przedborski S Mol Cell Neurosci; 2013 Jul; 55():37-43. PubMed ID: 22926193 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]